Myelodysplastisches Syndrom · Preleukemia · Myelodysplasia · Refractory anemia in dogs
Myelodysplastic syndrome (MDS) is a severe disorder of the bone marrow, which is the tissue inside bones responsible for producing blood cells. In affected dogs, the bone marrow produces abnormal, immature blood cells that fail to develop properly and cannot function. This leads to a critical shortage of healthy red blood cells, white blood cells, or platelets in the bloodstream. A bone marrow biopsy or aspirate is the essential diagnostic test used to confirm this abnormal cell development and distinguish MDS from leukemia.
Owners may notice signs of severe weakness, pale gums, frequent infections, or tiny purple spots on the skin caused by bleeding. While this condition is most commonly diagnosed in older dogs, it can occasionally develop in younger animals.
MDS is generally incurable and requires lifelong supportive care, such as blood transfusions and medications to stimulate cell production. Managing this condition is intensive, with typical treatment costs ranging from 2,000 to 8,000 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the Spine.